difference between insulin and glp 1 The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP1 Receptor Agonists—Effects beyond Obesity

New research suggests GLP-1s may reduce the risks of blood clots and early death in people with both obesity and autoimmune disease

At low doses, GLP-1 agonists have been observed to reduce alcohol cravings, lower the frequency and volume of drinking and in some individuals produce a natural disinterest in alcohol altogether

A patient experiencing significant tachycardia while on tirzepatide should discontinue the medication immediately if they have postural orthostatic tachycard...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.

Skip the delays and hidden costs